Healthcare professionals, business leaders, and innovators from across Asia and beyond will converge at Makuhari Messe for MEDICAL JAPAN 2025 TOKYO to experience an immersive exhibition of medical, elderly care, pharmacy, and healthcare, with over 650 exhibitors and an anticipated 18,000 visitors from October 1 to 3, 2025.
Researchers in Japan have demonstrated that acoustic waves in the audible frequency range can directly modulate gene expression in mammalian cells and significantly inhibit adipocyte differentiation. The study reveals a novel mechanotransduction pathway linking sound stimulation to cellular responses via focal adhesion signalling, opening potential applications in regenerative medicine and biotechnology.
New research has shown hospital patients could reduce the carbon footprint and saturated fat content of their selected meals by up to almost a third through strategic reorganisation of weekly menus without removing any dishes, according to a University of Bristol study published in Philosophical Transactions of the Royal Society B.
Researchers at Emory University have demonstrated that GPT-5, the latest large language model from OpenAI, significantly outperforms human medical experts on standardised diagnostic reasoning tasks. The AI achieved remarkable accuracy rates exceeding 95% on medical licensing examinations whilst showing particular strength in integrating visual and textual clinical information.
GE HealthCare has announced the launch of its most advanced cardiovascular ultrasound system, the Vivid Pioneer, featuring next-generation AI automation and enhanced imaging capabilities designed to transform cardiac diagnostic workflows. The ultra-premium system has received both CE Mark approval and U.S. FDA 510(k) clearance, positioning it for global deployment in cardiovascular care settings.
Researchers have engineered sophisticated human brain organoids that faithfully model myelin production and repair processes. The groundbreaking model integrates immune cells called microglia, revealing their essential role in remyelination and providing a powerful new platform for testing potential multiple sclerosis therapies.
A novel soft robotic device has enabled emergency medical personnel to achieve intubation success rates as high as 96% with only five minutes of training, according to new research published in Science Translational Medicine. The vine-like device could dramatically expand access to life-saving airway management in emergency situations and resource-limited settings.
Philips has unveiled Transcend Plus, the next generation of its EPIQ CVx and Affiniti CVx cardiovascular ultrasound systems, delivering significant advancements in artificial intelligence integration and image quality enhancement.
Scientists have engineered a portable 3D printing device that produces bone grafts directly onto fractures during surgery. The technology enables real-time fabrication of customised implants without pre-operative preparation, whilst incorporating antibiotics to prevent infection and promoting natural bone regeneration at the grafting site.
Phraxis, Inc. has successfully completed the world’s first commercial case using its FDA-approved EndoForceAnastomotic Connector, establishing a pivotal milestone in dialysis vascular access innovation. The groundbreaking procedure, performed at Spartanburg Regional Medical Center in South Carolina, signals the beginning of U.S. commercialisation for this novel endovascular device designed to standardise arteriovenous graft creation.
April 2024
Beukenlaan 137
5616 VD Eindhoven
The Netherlands
+31 85064 55 82
info@interhospi.com
PanGlobal Media IS not responsible for any error or omission that might occur in the electronic display of product or company data.